Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women-Reference-Cited by-同舟云学术

Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women

Published:2023-08 Issue: Volume:73 Page:36-47
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Bjertrup Anne Juul,Væver Mette Skovgaard,Miskowiak Kamilla Woznica^ORCID

Funder

TrygFonden

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference58 articles.

1. The Antenatal Risk Questionnaire (ANRQ): acceptability and use for psychosocial risk assessment in the maternity setting;Austin;Women Birth,2013

2. Is Postpartum Depression Different From Depression Occurring Outside of the Perinatal Period? A Review of the Evidence;Batt;Focus (Am. Psychiatr. Publ.),2020

3. Predictors of postpartum depression: an update;Beck;Nurs. Res.,2001

4. Normalization of enhanced fear recognition by acute SSRI treatment in subjects with a previous history of depression;Bhagwagar;Am. J. Psychiatry,2004

5. Cognitive processing of infant stimuli in pregnant women with and without affective disorders and the association to postpartum depression;Bjertrup;Eur. Neuropsychopharmacol.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Affective cognition in response to infant stimuli in pregnant compared with non-pregnant women;Women & Health;2024-05-14

2. Can cognition screening in the clinic aid personalised treatment in bipolar disorder?;European Neuropsychopharmacology;2024-04

3. The never-ending problem: Sample size matters;European Neuropsychopharmacology;2024-02

4. Maternal Stress, Anxiety, Well-Being, and Sleep Quality in Pregnant Women throughout Gestation;Journal of Clinical Medicine;2023-11-26

5. Prevention and treatment of Postpartum Mania, Psychosis, and psychotic depression;European Neuropsychopharmacology;2023-09